Delivery Order SPE2DB20D7061-SPE2DB24FSLR0
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Xifaxan 550 mg tablets. The contract has a ceiling value of $21,803.56 and runs through August 9, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, which serves as the primary vehicle for the company to provide a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,271.54, is for the delivery of Xifaxan 550 mg tablets. The contract has a period of performance through November 20, 2024 and utilizes a firm fixed price pricing structure. This award is a delivery order under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Xifaxan 550 mg tablets. The contract has a ceiling value of $4,050.50 and is a firm fixed price delivery order with a completion date of November 14, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $10,087.24 firm fixed-price contract provides the DLA with 4,563,517,205 units of the drug Xifaxan 550 mg tablets. The contract has a completion date of February 2, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XIFAXAN 550 mg tablets. The $4,126.85 firm fixed-price contract has a completion date of June 11, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical...
- This federal contract award, valued at $9,027.48, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB25D3002|SPE2DB25FLQMG) for the supply of Xifaxan 550 mg tablets, a medication used to treat various gastrointestinal conditions. The contract has a firm-fixed-price structure and an ultimate completion date of April 23, 2025. AmerisourceBergen Drug Corp,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,828.29 Firm Fixed Price delivery order is for XIFAXAN 550 MG Tablets, a specialty medication used for various medical conditions. The contract has an ultimate completion date of August 18, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,747.00 firm fixed-price delivery order is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of February 14, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of XIFAXAN 550 mg tablets. The contract has a ceiling value of $9,118.61 and a completion date of August 23, 2024. AmerisourceBergen, a major pharmaceutical distributor in the United States, has been awarded this firm fixed-price contract to provide the specified medication to support federal healthcare programs and military treatment facilities. The...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XIFAXAN 550 mg tablets. The $8,907.45 firm fixed-price contract has a period of performance through May 8, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
- SPE2DB20D7061Indefinite Delivery Contract
- SPE2DB20D7061-SPE2DB24FSLR0Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The order is for Xifaxan 550 mg tablets and has a ceiling value of $12,553.49. The contract is a firm fixed-price delivery order with a completion date of December 21, 2023. There is no set-aside designation for this award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.6k | 12/20/23 |